-
PublishedJune 8, 2021
Commentary: Congress should stop rewarding Big Pharma with tax breaks for gouging patients
Maine’s congressional delegation should push to eliminate loopholes that allow this industry to dodge paying its fair share.
-
PublishedMay 27, 2021
Legislative panel votes down bill to penalize drug companies for price gouging
The pharmaceutical industry has made it clear that it will sue Maine if the state approves the ‘excessive pricing’ bill, which now goes to the full Legislature.
-
PublishedApril 10, 2021
Commentary: Don’t put Maine’s health care decisions in the hands of a third party
L.D. 675 could cost thousands of Maine patients and their families access to the medications that allow them to live fulfilling lives, says the mother of a chronically ill teen.
-
PublishedMarch 23, 2021
Maine Democrats’ bills aim to hold down prescription drug prices, health care costs
Their 5 bills include proposals to reduce price gouging by pharmaceutical companies and help consumers who have trouble paying for insulin.
-
PublishedAugust 12, 2020
Sen. Libby: Maine stands up to drug companies looking to profit off a crisis
Legislators have passed bills aimed at medication cost control and billing transparency – now we must focus on reining in the price of treating COVID.
-
PublishedApril 3, 2020
Our View: Don’t let companies off the hook for their role in opioid epidemic
An investigation by ProPublica found evidence that Walmart sent millions of doses of opioid painkillers to criminal doctors.
-
PublishedApril 3, 2020
Our View: Don’t let companies off the hook for their role in opioid epidemic
ProPublica describes how the Justice Department stopped the prosecution of Walmart for filling suspicious prescriptions, in Maine and around the country.
-
PublishedNovember 29, 2019
Another View: Sen. Collins’ bill would address drug shortage
A trade association backs the MEDs Act, which would create incentives to increase the supply of prescription medications.
-
PublishedNovember 20, 2019
Commentary: Congress has an opportunity to lower drug costs – and there’s no time to waste
People who take insulin are among those hardest hit by spiraling expenses. A new medication pricing bill would help them.
-
PublishedNovember 19, 2019
Commentary: Collins’ bill fails to address root cause of drug shortages
She knows what the problem is: pricing and contracting practices that benefit suppliers and hospital executives at patients' expense.
prescription drugs
advertisement